We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

266 hedge funds and large institutions have $4.24B invested in Immunogen Inc in 2023 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

426% more capital invested

Capital invested by funds: $805M → $4.24B (+$3.43B)

304% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 25

93% more call options, than puts

Call options by funds: $69.3M | Put options by funds: $35.8M

40% more funds holding

Funds holding: 190 → 266 (+76)

7% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 72

Holders
266
Holders Change
+76
Holders Change %
+40%
% of All Funds
4.18%
Holding in Top 10
13
Holding in Top 10 Change
+13
Holding in Top 10 Change %
% of All Funds
0.2%
New
101
Increased
67
Reduced
72
Closed
25
Calls
$69.3M
Puts
$35.8M
Net Calls
+$33.4M
Net Calls Change
+$21.4M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$114M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$103M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$74.2M
4
FFM
Fairmount Funds Management
Pennsylvania
+$71.2M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$70M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$231M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$201M
3
State Street
State Street
Massachusetts
-$108M
4
MC
Maverick Capital
Texas
-$48M
5
Morgan Stanley
Morgan Stanley
New York
-$47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
151
Allianz Asset Management
Germany
$1.03M +$498K +42,200 +346%
Franklin Resources
152
Franklin Resources
California
$1.01M +$634K +53,686 New
Natixis Advisors
153
Natixis Advisors
Massachusetts
$992K +$621K +52,572 New
Osaic Holdings
154
Osaic Holdings
Arizona
$966K -$147K -12,448 -20%
IECM
155
Intrinsic Edge Capital Management
Illinois
$944K +$590K +50,000 New
ProShare Advisors
156
ProShare Advisors
Maryland
$920K +$96.6K +8,184 +20%
ZIM
157
Zacks Investment Management
Illinois
$910K +$569K +48,218 New
EAM
158
Erste Asset Management
Austria
$883K – – –
Los Angeles Capital Management
159
Los Angeles Capital Management
California
$854K +$535K +45,280 New
Axa
160
Axa
France
$845K +$141K +11,900 +36%
TSW
161
Thompson Siegel & Walmsley
Virginia
$793K +$496K +42,000 New
Ameriprise
162
Ameriprise
Minnesota
$789K -$2.89M -245,052 -85%
SG Americas Securities
163
SG Americas Securities
New York
$769K -$70.6K -5,976 -13%
DT
164
Diversified Trust
Tennessee
$768K +$19.1K +1,614 +4%
US Bancorp
165
US Bancorp
Minnesota
$757K +$471K +39,912 +17,582%
FAM
166
Fred Alger Management
New York
$729K +$456K +38,658 New
Zurich Cantonal Bank
167
Zurich Cantonal Bank
Switzerland
$709K +$88K +7,452 +25%
CC
168
Centiva Capital
New York
$669K +$419K +35,454 New
GCP
169
GSA Capital Partners
United Kingdom
$667K +$65.7K +5,564 +19%
Handelsbanken Fonder
170
Handelsbanken Fonder
Sweden
$660K +$80.3K +6,800 +24%
Public Employees Retirement Association of Colorado
171
Public Employees Retirement Association of Colorado
Colorado
$659K – – –
RJFSA
172
Raymond James Financial Services Advisors
Florida
$616K -$263K -22,291 -41%
QT
173
Quantamental Technologies
New York
$590K +$369K +31,249 New
CAM
174
ClariVest Asset Management
California
$580K -$1.02M -86,169 -74%
AB
175
Amalgamated Bank
New York
$574K +$50.7K +4,293 +16%
5 6
7
8 9

IMGN Hedge Fund Activity: Q2 2023 in Review

266 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2023, worth a combined $4.24B — up 426% from $805M a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new IMGN positions and 25 closed out — a net gain of 76 holders — while 67 added to existing stakes and 72 trimmed.

The largest buyer was Redmile Group, adding an estimated $114M. The largest seller was RA Capital Management, cutting an estimated $231M.

  • 266 institutional investors held Immunogen Inc (IMGN) as of Q2 2023, up from 190 in Q1 2023.
  • Funds reported $4.24B of Immunogen Inc stock for Q2 2023, up 426% quarter-over-quarter.
  • 101 funds opened new Immunogen Inc positions in Q2 2023 and 25 closed out, a net change of +76 holders.
  • The largest Immunogen Inc buyer in Q2 2023 was Redmile Group, an estimated $114M added.
  • The largest Immunogen Inc seller in Q2 2023 was RA Capital Management, an estimated $231M sold.

Based on aggregated 13F filings for Q2 2023.